Trial · NCT02232516
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Study Treatment Period: Cycles 1-3 | STARTED | Treatment (Romidepsin, Lenalidomide) | 30 | |
| Study Treatment Period: Cycles 1-3 | Cycle 1 | Treatment (Romidepsin, Lenalidomide) | 29 | |
| Study Treatment Period: Cycles 1-3 | Cycle 2 | Treatment (Romidepsin, Lenalidomide) | 23 | |
| Study Treatment Period: Cycles 1-3 | Cycle 3 | Treatment (Romidepsin, Lenalidomide) | 20 | |
| Study Treatment Period: Cycles 1-3 | 1st Response Assessment | Treatment (Romidepsin, Lenalidomide) | 23 | |
| Study Treatment Period: Cycles 1-3 | COMPLETED | Treatment (Romidepsin, Lenalidomide) | 20 | |
| Study Treatment Period: Cycles 1-3 | NOT COMPLETED | Treatment (Romidepsin, Lenalidomide) | 10 | |
| Study Treatment Period: Cycles 4-6 | STARTED | Treatment (Romidepsin, Lenalidomide) | 20 | |
| Study Treatment Period: Cycles 4-6 | Cycle 4 | Treatment (Romidepsin, Lenalidomide) | 15 | |
| Study Treatment Period: Cycles 4-6 | Cycle 5 | Treatment (Romidepsin, Lenalidomide) | 13 | |
| Study Treatment Period: Cycles 4-6 | Cycle 6 | Treatment (Romidepsin, Lenalidomide) | 13 | |
| Study Treatment Period: Cycles 4-6 | 2nd Response Assessment | Treatment (Romidepsin, Lenalidomide) | 12 | |
| Study Treatment Period: Cycles 4-6 | COMPLETED | Treatment (Romidepsin, Lenalidomide) | 13 | |
| Study Treatment Period: Cycles 4-6 | NOT COMPLETED | Treatment (Romidepsin, Lenalidomide) | 7 | |
| Study Treatment Period: Cycles 7-9 | STARTED | Treatment (Romidepsin, Lenalidomide) | 13 | |
| Study Treatment Period: Cycles 7-9 | Cycle 7 | Treatment (Romidepsin, Lenalidomide) | 6 | |
| Study Treatment Period: Cycles 7-9 | Cycle 8 | Treatment (Romidepsin, Lenalidomide) | 4 | |
| Study Treatment Period: Cycles 7-9 | Cycle 9 | Treatment (Romidepsin, Lenalidomide) | 3 | |
| Study Treatment Period: Cycles 7-9 | 3rd Response Assessment | Treatment (Romidepsin, Lenalidomide) | 3 | |
| Study Treatment Period: Cycles 7-9 | COMPLETED | Treatment (Romidepsin, Lenalidomide) | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02232516/flow